booom!! what been waiting for. great work NOX. commerical deals in USA on the horizon.
U.S. Food and
Drug Administration (FDA) has approved the Investigational New Drug (IND) application for
Veyonda® for combination treatment with doxorubicin in patients with soft tissue sarcomas.
FDA for being a safe and well-tolerated drug.”
Ann: FDA grants IND approval to Veyonda, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
-0.006(7.69%) |
Mkt cap ! $21.04M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.0¢ | 7.2¢ | $52.57K | 665.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 6221 | 2 |
View Market Depth
| Last trade - 15.56pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
-0.006 ( 5.33 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 23246 | ||
| Last updated 14.13pm 17/05/2024 ? | |||||
| NOX (ASX) Chart |